Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

euroderm otc s.p.a. - ispaghula (psillio semi) - ispaghula (psillio semi)

Unione Europea - italiano - EMA (European Medicines Agency)

incline therapeutics europe ltd - fentanil cloridrato - dolore postoperatorio - analgesici - ionsys è indicato per la gestione del dolore post-operatorio acuto da moderato a severo in pazienti adulti.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - tonsilla d28, acidum ascorbicum d6, nodus lymphaticus sono d8, midollo ossium rubra suis d10, funiculus umbilicalis d10, splen d10, ipotalamo d10, hepar d10, embrione suis d13, corteccia glandulae suprarenalis suis d13, cortisoni acetas d13, pulsatilla pratensis d6, acidum l(+) lacticum d6, echinacea d4, calcii phosphas d10, aesculus hippocastanum d6, kalii stibyli tartras d6, solanum dulcamara d4, levothyroxinum d13, dactylopius coccus d6, ferrum phosphoricum d10, gentiana lutea, d6, geranium robertianum d - injektionslösung - tonsilla d28, acidum ascorbicum d6, nodus lymphaticus sono d8, midollo ossium rubra suis d10, funiculus umbilicalis d10, splen d10, ipotalamo d10, hepar d10, embrione suis d13, corteccia glandulae suprarenalis suis d13, cortisoni acetas d13, pulsatilla pratensis d6, acidum l(+) lacticum d6, echinacea d4, calcii phosphas d10, aesculus hippocastanum d6, kalii stibyli tartras d6, solanum dulcamara d4, levothyroxinum d13, dactylopius coccus d6, ferrum phosphoricum d10, gentiana lutea, d6, geranium robertianum d6, mercurius solubilis hahnemanni d13, barii carbonas d28, conium maculatum d4, galium aparine d6, zolfo d8 ana partes, natrii chloridum, aqua ad iniectabilia, pro vitro. - ohne indicatore - homöopathische arzneimittel

Unione Europea - italiano - EMA (European Medicines Agency)

janssen-cilag international nv - fentanil cloridrato - dolore postoperatorio - analgesici - gestione del dolore acuto post-operatorio da moderato a grave da utilizzare solo in ambiente ospedaliero.

Unione Europea - italiano - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

eumedica pharmaceuticals gmbh - associazioni di sulfamidici con trimetoprim, inclusi i derivati - associazioni di sulfamidici con trimetoprim, inclusi i derivati

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

k24 pharmaceuticals s.r.l. - amoxicillina - amoxicillina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

k24 pharmaceuticals s.r.l. - cefuroxime - cefuroxime

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

k24 pharmaceuticals s.r.l. - cefaclor - cefaclor

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

k24 pharmaceuticals s.r.l. - benzilpenicillina - benzilpenicillina